What insurance covers Wegovy?
Glucagon-like peptide-1 receptor agonist medications (GLP-1s) and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists, such as Wegovy and Zepbound, have become very popular for their uses in weight management. But without insurance, these medications can be very expensive, costing over $1000 per month.
Insurance coverage for weight loss drugs depends on the type of insurance you have, your specific plan, and whether you meet certain criteria for the prescription.
Whether insurance covers GLP-1s depends on your plan, your health conditions, and which GLP-1 is prescribed. Denials for GLP-1s are common.
Insurance may only cover GLP-1s for an approved purpose. Using a GLP-1 for a use not approved by the FDA is known as off-label prescribing. This is safe and legal, but insurance is less likely to cover off-label uses.
You may also need to meet certain prescribing criteria to ensure that the medication is medically necessary for you. This usually means you need to have overweight or obesity, or show you have other weight-related conditions.
Finally, your insurer may need proof that the treatment is necessary for you in a process known as prior authorization.
Prior authorization is when your insurance provider requires a doctor to prove that a treatment is medically necessary before agreeing to cover the cost.
If a GLP-1 for weight management requires prior authorization, insurers may ask the prescribing doctor to show:
The doctor will handle this process, and you won’t need to do much yourself.
Once prior authorization forms are submitted, the decision may take up to 2 weeks. The insurance company might:
If coverage is denied, you may be able to appeal the decision. If it’s denied again and your prescription is still valid, you can still get the medication, but you will need to cover the cost yourself.
“Most prior authorizations are completed in about 5 days for standard requests or 24 hours if urgent, depending on the type of insurance coverage. You will usually be notified through your pharmacy, prescriber, or by a mailed letter or secure message from your insurer once the decision is made.”
Insurance coverage for weight loss medications like Wegovy might vary depending on whether you have private or federal insurance.
Medicaid coverage for weight loss medications is highly variable and depends on the state you live in.
Pro tip: If your state doesn’t cover GLP-1s for weight loss, check to see if you qualify due to a secondary weight-related condition. For example, if you have cardiovascular disease linked to your weight, it may be easier to get coverage.
In the past, with Medicare Part D plans, coverage was only possible if the GLP-1 was prescribed for a secondary condition, such as type 2 diabetes or reducing the risk of a major cardiovascular event, such as a heart attack or stroke. However, this is beginning to change with new legislation.
To improve access, the government has introduced a temporary program for the second half of 2026 that allows you to access certain GLP-1s for weight loss while long-term legislation is being finalized.
The Wegovy injection and oral tablets and the Zepbound KwikPen are eligible for this program, where you’ll pay a flat $50 monthly copay. The Centers for Medicare & Medicaid Services (CMS) will cover the remaining balance of the $245 monthly cost.
From 2027, the government is looking to introduce something called the BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive Health) model, which aims to permanently include GLP-1s for weight loss in the standard benefit package.
If enough Part D plans opt in, this model will be introduced in January 2027. With this model, you’ll likely need to enroll in lifestyle prgrams to support your treatment.
There is wide variation between employer and individual plans as to whether GLP-1s for weight loss are covered. GLP-1 coverage is often limited, but it may be expanding. Even if the drug is covered, your personal out-of-pocket costs can be high.
A 2024 study found that 18% of large companies with 200 or more employees covered GLP-1s when prescribed primarily for weight loss or conditions related to their approved uses, and 28% of employers that have 5,000 or more workers covered GLP-1s for weight loss.
Optum Perks is owned by RVO Health. By clicking on this link, we may receive a commission. Learn more.
Whether or not GLP-1s and GIP/GLP-1s for weight loss, like Wegovy, are covered by your insurance is highly variable in 2026. You may need to ensure you’re prescribed a GLP-1 approved for weight loss and meet certain criteria before an insurer will cover the medication.
Medicare programs are in the process of expanding coverage to medications for weight loss, whereas Medicaid coverage depends on your state.
Consider reaching out to a doctor or pharmacist to discuss costs and coverage for weight loss medications.
